Galleri Cancer Screening
Early Detection, Empowered Health: Discover Cancer Risk
Galleri Multi-Cancer Early Detection Test
The Galleri test is a groundbreaking blood test designed to detect a shared cancer signal across more than 50 types of cancer, many of which lack recommended screening tests today. By analyzing cell-free DNA (cfDNA) in the bloodstream, Galleri identifies abnormal methylation patterns that may indicate the presence of cancer. This enables earlier detection, allowing for more effective treatment and improved outcomes.
The Galleri Testing Process
The Galleri testing process is designed to be simple and convenient. It begins with a standard blood draw, typically conducted in a healthcare setting. Once the sample is collected, it is sent to a specialized laboratory where it undergoes advanced analysis to detect ctDNA. Results are typically available within 10 to 14 days, allowing for timely follow-up consultations with healthcare providers. Patients can expect clear and actionable insights, which help inform their healthcare decisions and next steps. This streamlined process ensures that individuals can easily incorporate Galleri into their routine health screenings without the need for invasive procedures or lengthy testing protocols.
Integrating Galleri into Your Healthcare Journey
At Colorado Integrative Healthcare, we understand that proactive health management is essential for maintaining well-being. Integrating Galleri into your healthcare journey allows for a comprehensive assessment of your cancer risk, fostering informed conversations with your healthcare team. Whether you’re beginning to explore cancer screening options or seeking to enhance your existing preventive health strategies, Galleri can play a crucial role. Our dedicated team is here to guide you through the process, from understanding your results to discussing potential next steps based on your individual risk profile. With Galleri, you have the opportunity to take charge of your health and make informed decisions for a healthier future.
Galleri can identify cancer signals before symptoms appear, including for cancers that currently have no recommended screening tests.
The test requires only a blood draw, making it a convenient addition to routine healthcare visits.
When a cancer signal is detected, Galleri predicts the tissue or organ associated with the signal, aiding healthcare providers in determining appropriate follow-up steps.
Clinical studies have demonstrated Galleri's ability to detect cancers with a low false-positive rate of less than 1%, minimizing unnecessary anxiety and procedures.
Frequently Asked Questions
